Evaluation of the efficacy and patient compliance to different treatment modalities for erectile dysfunction after nonnerve sparing radical retropubic prostatectomy (NNSRRP)

By Gontero P.   Fontana F.   Sogni F.   Crivellaro S.   Pretti G.   Sala M.   Favro M.   Ceratti G.   Frea B.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 177-177

Elsevier

Access to resources Recommend Favorite

Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer

By Incrocci L.   Hop W.C.J.   Slob A.K.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 116-120

Elsevier

Access to resources Recommend Favorite

Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study - endogtenous bimodal modulators of the GABA receptor: mechanism of action and physiological significance

By Reiter W.J.   Pycha A.   Schatzl G.   Pokorny A.   Gruber D.M.   Huber J.C.   Marberger M.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 590-594

Elsevier

Access to resources Recommend Favorite

Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate - an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction

By Zelefsky M.J.   Mckee A.B.   Lee H.   Leibel S.A.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 775-778

Elsevier

Access to resources Recommend Favorite

A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction

By Goldstein I.   Payton T.R.   Schechter P.J.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 301-305

Elsevier

Access to resources Recommend Favorite